It has further been demonstrated that glycine enhances insulin secretion directly from human β cells of T2D and non-T2D donors (5) and that circulating levels of glycine are inversely correlated with T2D risk (6–11), insulin resistance (12–14), impaired glucose tolerance (15, 16), and obesity (14, 17). This evidence concerns the gene INS and type 2 diabetes mellitus.